Print PDF

FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law


Ronald Reagan Building and International Trade Center
1300 Pennsylvania Avenue NW
Washington, DC 20004

Sheppard Mullin Participants:
Allison Fulton - "Innovative and Breakthrough Devices and Evolving Regulatory Pathways," May 7, 2:40–3:40 p.m
Christopher Van Gundy - "Food for Thought: Personalized Nutrition, 'Functional Foods', and FDA Regulation" May 7, 2:40–3:40 p.m

The premier conference for the food and drug law community, the FDLI Annual Conference addresses complex legal, regulatory, compliance, and policy issues across all facets of FDA-regulated industry. The two-day event provides in-depth discussions and analyses on a wide variety of timely topics by bringing together experts from the federal government, industry, the private bar, non-profits, patient and consumer advocates, consulting organizations, and academia.

Conference Highlights: 

  • Hear FDA’s 2020 strategic priorities directly from the FDA Commissioner, Chief Counsel, Center Directors, and other key leaders within the Agency
  • Join 900 high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding
  • Select from over 35 breakout sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues
  • Learn from more than 100 well-known officials and experts
  • Hear about the Top Cases in Food and Drug Law
  • Network and build relationships with seasoned law, regulatory, compliance, marketing/advertising, and management professionals

Key FDA Speakers:

  • Stacy Cline Amin, Chief Counsel, FDA
  • Peter W. Marks, Director, Center for Biologics Evaluation and Research, FDA  
  • Susan T. Mayne, Director, Center for Food Safety and Applied Nutrition, FDA
  • Jeffrey E. Shuren, Director, Center for Devices and Radiological Health, FDA
  • Steven M. Solomon, Director, Center for Veterinary Medicine, FDA
  • Janet Woodcock, Director, Center for Drug Evaluation and Research, FDA
  • Mitchell R. Zeller, Director, Center for Tobacco Products, FDA

Click here for more information and registration.

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.